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SUMMARY
Embryonic stem cells (ESCs) are regulated by pluripotency-related transcription factors in concert with chromatin regulators. To identify
additional stem cell regulators, we screened a library of endogenously labeled fluorescent fusion proteins in mouse ESCs for fluorescence
loss during differentiation. We identified SET, which displayed a rapid isoform shift during early differentiation from the predominant
isoform in ESCs, SETa, to the primary isoform in differentiated cells, SETb, through alternative promoters. SETa is selectively bound and
regulated by pluripotency factors. SET depletion causes proliferation slowdown and perturbed neuronal differentiation in vitro and devel-
opmental arrest in vivo, and photobleaching methods demonstrate SET’s role in maintaining a dynamic chromatin state in ESCs. This
work identifies an important regulator of pluripotency and early differentiation, which is controlled by alternative promoter usage.
INTRODUCTION
Embryonic stem cells (ESCs), derived from the inner cell
mass of preimplantation embryo, have the capability to
give rise to all cell types of an adult organism (Evans and
Kaufman, 1981). Although considerable attention has
been devoted to the biology of ESCs, we are still far from
understanding the complete underlying molecular mecha-
nisms that govern pluripotency and lineage flexibility. To
date, a core set of transcription factors (TFs) in concert
with chromatin regulators has been identified, maintain-
ing the ‘‘stem cell state’’ (Chambers and Tomlinson,
2009; Lessard and Crabtree, 2010; Loh et al., 2011).
Chromatin has been at the focal point in stem cell
biology due to a variety of roles it plays in conferring and
maintaining pluripotency (Fazzio et al., 2008; Gaspar-
Maia et al., 2009; Lessard and Crabtree, 2010). Extensive
modifications and rearrangements both at the global and
local levels take place in chromatin structure during differ-
entiation of ESCs (Meshorer and Misteli, 2006; Yamazaki
et al., 2007), from a more dynamic, permissive structure
in the pluripotent state to a restricted conformation
following differentiation (Efroni et al., 2008). Some of the
factors responsible for this hyperdynamic plasticity have
recently begun to emerge, and include histone acetylation
andmethylation (Melcer et al., 2012), several histonemod-
ifiers and chromatin remodeling proteins (Cervoni et al.,
2002; Gaspar-Maia et al., 2009; Ho et al., 2009), as well as
the nuclear lamina protein Lamin A (Melcer et al., 2012).
Despite this extensive research, additional regulators of
pluripotency are still being identified (Betschinger et al.,
2013; Cheloufi et al., 2015; Ho et al., 2015; Respuela
et al., 2016), and it is clear that additional factors await
discovery.
To identify additional stem cell regulators, we generated a
library of endogenously labeled fluorescent fusion proteins
in R1mouse ESCs (Harikumar et al., 2017 [this issue of Stem
Cell Reports]). Here, we report that SET nuclear oncogene
(SET, also known as TAF-I), amultifunctional linker histone
chaperone, undergoes an isoform switch during early ESC
differentiation via alternative promoters, and is involved
in regulating pluripotency, proliferation, and differentia-
tion of mouse ESCs.
RESULTS
Screening for Downregulated Proteins during ESC
Differentiation
To identify potential regulators of pluripotency and ESC
differentiation, we screened for proteins that are downre-
gulated early upon retinoic acid (RA)-induced differentia-
tion. Fluorescence levels, representing endogenous protein
levels, were monitored using live time-lapse microscopy
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over 4 days. Using this screen, we identified SET nuclear
oncogene (SET), which was rapidly downregulated after
the induction of differentiation (Figures 1A–1C and Movie
S1). As expected from previous reports (Kato et al., 2011),
SET was mainly found in the nucleus (Figures 1A and
S1A–S1C). Interestingly, SET protein levels appear to reflect
the differentiation state of ESCs in culture, with undifferen-
tiated colonies showing high fluorescence and early differ-
entiating colonies or colony edges showing reduced fluo-
rescence (Figure S1B). These results suggest that SET is
predominantly expressed in ESCs (Figures S1B–S1D) and
is reduced during ESC differentiation, and that our N-ter-
minal YFP tag of SET (Figure 1B) did not alter its nuclear
localization.
Alternative Promoters Give Rise to Two Different SET
Isoforms
The Set gene is located on chromosomes 2 and 9 in mouse
and human, respectively. The Set gene is alternatively
spliced, with four transcripts predicted to give rise to pro-
tein products of varying sizes (Figure S1E). SET is well
conserved across species, with mouse and human SET pro-
teins sharing 94% similarity. SET has two prominent iso-
forms, SETa and SETb (Matsumoto et al., 1993; Nagata
et al., 1995) (Figures 1E–1G and S1E–S1H). SET isoforms
share most of the coding sequence except the first exons
(Figure 1B), thus giving rise to almost identical proteins,
which differ only at their N terminus (Figure 1D). SETa
has a 36-amino-acid (aa) a-specific region and SETb has a
24-aa b-specific region (Nagata et al., 1995). A dimerization
domain and a highly acidic C-terminal domain, which is
important for binding acetylated proteins such as p53
(Wang et al., 2016), follow these unique N-terminal iso-
form-specific regions (Figure 1D). SETb is the most widely
expressed isoform in differentiated cells, whereas SETa is
expressed in a limited number of differentiated cell types
and is usually expressed at considerably lower to non-exis-
tent levels compared with the b isoform (Nagata et al.,
1998). In our YFP-SET clone, the YFP was integrated in
intron 1, after the SETa-specific 50 exon (Figure 1B), and
therefore only SETa, and not SETb, is tagged by YFP, conve-
niently allowing us to distinguish between the two iso-
forms. To measure the levels of the SETa- and SETb-specific
isoforms in ESCs, we performed qPCR analysis using
primers specific to the unique 50 exons. The expression
level of SETa was considerably higher than that of SETb
in ESCs both at RNA and protein level (Figures S1H and
1G). Interestingly, SETa mRNA decreased rapidly during
differentiation with a gradual concomitant rise in SETb
levels (Figures 1E and 1F), demonstrating an isoform switch
at the transcriptional level. Western blots using anti-SET
antibodies that recognize both isoforms show that the
SETa decreased rapidly and SETb levels increased moder-
ately during differentiation (Figure 1G). Finally, RNA
sequencing (RNA-seq) tracks from ESCs and mouse embry-
onic fibroblasts (MEFs) from different sources (Shen et al.,
2012; Yue et al., 2014) provided further support for the
SETa/SETb isoform switch between ESCs and MEFs at the
RNA level (Figure 1H). Since we readily detected both
YFP-tagged SET and native SET in the YFP-SET clone (Fig-
ure S1F), we conclude that SET expression is biallelic.
Core Pluripotency Factors Bind and Regulate SETa
Expression
The unique elevated levels of SETa in ESCs and its abrupt
decrease during differentiation called for testing its
expression regulation. To this end, we used publicly
available datasets (Chen et al., 2008; Marson et al.,
2008) of epigenetic modifications and TF binding maps,
as well as the BindDB webtool, recently developed by
our group (Aaronson et al., 2016; Livyatan et al., 2015),
enabling in silico reverse-chromatin immunoprecipita-
tion (ChIP) analysis, to search for potential emerging fea-
tures of the SET promoter(s). Our in silico analysis re-
vealed that the upstream regions of both SETa and
SETb 50 exons are enriched for H3K4me3 (Figure S2A,
bottom), a mark of active transcription. This nicely de-
picts the existence and location of the alternative SET
promoters. As expected from an active gene, we did not
find any enrichment for H3K27me3 in these promoter
regions (Figure S2A). Analyzing the binding of TFs to
SET promoters, we found that at least nine TFs, many
of which are ESC specific, bind the SETa, but not the
SETb, promoter (Figure 2A). BindDB analysis revealed
that none of the pluripotency factors bind the SETb pro-
moter, which was instead bound by factors such as TOP-
OIIa, TET1, OGT, HDAC2, FBXL10, CAPG, and CTR9,
suggesting a more poised state (Figure 2A). The binding
of SETa promoter by OCT4, SOX2, KLF4, and NANOG
was confirmed by ChIP-qPCR (Figure 2B). These data sug-
gest that the two isoforms are distinctly regulated and
that the SETa promoter alone is bound by the pluripo-
tency network TFs.
OCT4 Regulates SETa Expression in ESCs
Next, we wished to test the functional significance of the
binding of the pluripotency factors to the SETa promoter.
To determine the effect of OCT4 on SETa expression, we
took advantage of the Zhbtc4 ESC system, in which
endogenous Oct4 gene is under the control of doxycycline
(Dox) (Niwa et al., 2000). Addition of Dox completely
abolishes OCT4 expression (Figures 2C and 2F). While
OCT4-depleted cells began to differentiate after 48 hr,
24 hr after Dox addition the Zhbtc4 ESC colonies remained
undifferentiated and appeared similar to the control col-
onies in morphology (Figure S2B) and Nanog expression
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Figure 1. A SET Isoform Switch during Early ESC Differentiation
(A) Time-lapse images of SETa-YFP cells during the first 50 hr of RA-induced ESC differentiation. Scale bar, 50 mm.
(B) Schematic showing the gene structure of the two SET isoforms and YFP-SETa.
(C) Anti-GFP western blots of SET-YFP during ESC differentiation. GAPDH was used as control.
(D) Protein domain model depicting the SETa and SETb isoforms. Shown are SETa-specific region (blue), SETb-specific region (violet),
dimerization domain (orange), and acidic domain (red).
(E and F) qRT-PCR analysis of SETa (E) (*p < 0.001, **p % 1.6 3 105, 2-tailed Student’s t test) and SETb (F) mRNA level during ESC
differentiation (Data are shown as mean ± SD; n = 3 independent experiments).
(G) Anti-SET western blots showing SETa and SETb isoforms during ESC differentiation. GAPDH was used as loading control. Differentiation
was carried out in ESC medium with RA (1 mM) and without LIF on gelatin-coated plates.
(H) RNA-seq tracks showing evidence for SETa and SETb expression in ESCs and MEFs.
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(Figure 2C). Importantly, SETa, but not SETb, was selec-
tively decreased (by 50%) in the Dox-treated cells after
24 hr (Figures 2D and 2E), suggesting that SETa, but not
SETb, is controlled by OCT4. These results were confirmed
at the protein level (Figure 2F), although due to the higher
stability of the protein the effect is more subtle. Next, we
examined the previously published RNA polymerase II
(RNAPII) occupancy data in the Zhbtc4 cells after OCT4
depletion (Rahl et al., 2010), and found a selective decrease
at the SETa promoter 24 hr after Dox addition (Figure 2G).
Figure 2. SETa Expression Is Regulated by Pluripotency Factors in ESCs
(A) In silico reverse-ChIP analysis for SET. For every query, our BindDB webtool and pipeline returns the TFs and chromatin modifications
that are enriched at the promoter region (proximal or distal). Dark green, binding; light green, no binding. Green, blue, and red boxes
depict TFs or histone marks associated with active chromatin, pluripotency, or poised chromatin, respectively.
(B) ChIP analysis of pluripotency factors at the SETa promoter (left). SETa gene body corresponding to a region in intron 7 was used as a
negative control (right) (data are shown as mean ± SD; n = 3 independent experiments).
(C) qRT-PCR analysis of Oct4 and Nanog mRNA levels in Zhbtc4 cells before and after Dox treatment. Expression levels were normalized to
GAPDH (data are shown as mean ± SD; n = 3 independent experiments).
(D and E) qRT-PCR analysis of SETa (D) and SETb (E) mRNA levels in Zhbtc4 cells before and after Dox treatment. Expression levels were
normalized to GAPDH expression (data are shown as mean ± SD; n = 3 independent experiments).
(F) Western blots of SETa, SETb, and OCT4 in Zhbtc4 cells before and after Dox treatment. GAPDH was used as a loading control.
(G) Binding profiles of RNAPII at SETa and SETb promoters before (0 hr) and after (24 hr) Dox addition. Data are from Rahl et al. (2010).
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Taken together, these data demonstrate a highly selective
promoter-specific regulation of SETa, but not SETb, by
OCT4 and likely other pluripotency factors (Figure S2C).
SET Regulates Cell Proliferation and Survival of ESCs
To explore the role of SET in ESCs, we generated stable
knockdown (KD) clones of total SET, and used the
CRISPR/Cas9 system to selectively disrupt either SETa,
SETb, or both (SET-DKO) in mouse ESCs (Figures S3A–
S3C, 3A, and 3B). All KD and knockout (KO) clones were
verified by qPCR and western blotting, and KO clones
were further validated by sequencing. Interestingly, SETa
KO ESCs showed increased levels of SETb transcripts (Fig-
ure S3C). The SET-DKO clones grew slowly and formed
small colonies. We therefore reverted to analyzing the sta-
ble SET-KD clones, where most, but not all, of the protein
is depleted (Figures 3A and 3B). The morphology of the
SET-KD clones remained unaltered when grown on MEFs
(Figure S3D), as well as the expression level of OCT4,
NANOG, and KLF4 (Figures S3E and 3C). However, there
was a slight increase in the expression level of differentia-
tion markers of all three germ lineages (Figure S3F).
Figure 3. SET Regulates ESC Proliferation
(A) qRT-PCR analysis of SET knockdown efficiency (n = 3 independent biological experiments; *p < 0.005, 2-tailed t test). Expression levels
were normalized to GAPDH. Error bars represent ±SD.
(B) Western blots of SET in control (Scr-ctrl) and SET-KD cells. GAPDH was used as control.
(C) Western blots of pluripotency factors in SET-KD clones. GAPDH was used as control.
(D) The number of upregulated (blue) and downregulated (red) genes in undifferentiated SET-KD ESCs (left) and in RA-induced SET-KD cells
(right).
(E) Reduced proliferation in SET-KD ESCs (*p < 0.05, 2-tailed t test). Cell number of SET-depleted ESCs was normalized to Scr-ctrl cell
number. Error bars represent ±SD (n = 3 independent biological experiments).
(F) Cell-cycle analysis of SET-KD cells. Cell number in each phase was normalized to that of Scr-ctrl (n = 3 independent experiments; error
bars represent ±SD; *p < 0.05, 2-tailed t test).
(G) KH2-ESC proliferation assay following overexpression (OE) of SETa or SETb (n = 3 independent experiments; error bars represent ±SD).
(H) Representative images of clone formation assay of control (top), SETa-OE (bottom left), and SETb-OE (bottom right) wells. Colonies
were detected with AP staining (pink).
(I) Quantification of (H) (n = 3 independent experiments; error bars represent ±SD; *p < 0.05, 2-tailed t test).
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Expression microarrays confirmed a relatively minor effect
on gene expressionwith 67 and 120 genes reproducibly up-
regulated and downregulated (1.5-fold cutoff), respectively,
in the undifferentiated SET-KD clones (Figures 3D and
S3G–H; Table S1). A closer look at the downregulated genes
revealed a class of genes that are specifically involved in the
G2/M phase of the cell cycle, of which Cdc16 and Anapc4
govern the exit from mitosis. To test the role of SET on
cell-cycle kinetics, we performed proliferation assays in
SET-KD and SET-overexpressing (OE) cells. After 96 hr, we
observed a 40% decrease in cell numbers in the SET-KD
clones compared with controls (Figure 3E), without any
apparent influence on cell death. Fluorescence-activated
cell sorting-based cell-cycle analysis using propidium io-
dide revealed a shift from S to G2/M phase in the SET-KD
population (Figure 3F), suggesting that SET depletion slows
down cells in the G2/M phase. To test the effects of SET
overexpression on proliferation, we used KH2 ESCs (Sup-
plemental Experimental Procedures) to individually
overexpress either YFP-SETa, hemagglutinin (HA)-SETa,
or HA-SETb in ESCs (Figures S3I–S3K). We found that
SET overexpression increased ESC proliferation rates by
1.4-fold (Figure 3G).
We next tested the effect of the SET isoforms on impart-
ing survival advantage to ESCs. We performed a clone-for-
mation assay of SETa- or SETb-OE KH2 cells with and
without Dox, and stained the cells for alkaline phosphatase
(AP) 6 days later. SETa and SETb overexpression increased
colony numbers by 2.3-fold and 1.7-fold, respectively
(Figures 3H and 3I), indicating that SETcan impart survival
advantage, consistent with its effect on proliferation. The
fact that both SETa and SETb had similar effects suggests
that the N-terminal region of SET is not involved in these
processes. These results are also in line with observations
in cancer cell lines, where SET isoforms are greatly overex-
pressed, increasing the cancer cells’ survival rate and prolif-
erative capacity (Carlson et al., 1998; Fukukawa et al.,
2000).
SET Regulates Neuroectodermal Differentiation of
ESCs
To investigate the effect of SET-KD on ESC differentiation,
we induced control (Scr-ctrl) and SET-KD cells to differen-
tiate with RA (Figure 4A). By day 4, while Scr-ctrl cells differ-
entiated normally into NESTIN-positive cells as expected
(Figure 4B, top), the SET-KD clones formed Nestin-negative
circular colonies of small round cells, surrounded by
NESTIN-positive cells (Figure 4B, bottom). The cells within
the circular colonies were negative for the pluripotency
marker OCT4 (Figure 4C), suggesting that they did not
remain undifferentiated. Testing different lineage markers
we found that the OCT4-negative circular colonies ex-
pressed the early endodermal marker GATA4 (Figure 4D).
The Scr-ctrl cells were all negative for GATA4, as expected
Figure 4. SET Regulates ESC Neuronal Differentiation
(A) Phase contrast images of Scr-ctrl cells (left) and SET-KD cells (right). SET depletion results in circular colonies and aberrant neuronal
differentiation (arrows). Scale bars, 200 mm.
(B) Immunofluorescence (IF) for NESTIN (red) and RA-differentiated Scr-ctrl (top) and SET-KD cells (bottom). Nuclei were counterstained
with DAPI (blue, right). Note the characteristic circular structures in the KD clones. Scale bar, 200 mm.
(C) IF for OCT4 (red) in RA-differentiated Scr-ctrl (left) and SET-KD clones (right). Scale bar, 200 mm.
(D) IF for GATA4 (red) in RA-differentiated Scr-ctrl (top) and SET-KD ESCs (bottom). Nuclei were counterstained with DAPI (blue, right).
Scale bar, 200 mm.
(E and F) Time-course qRT-PCR analysis of pluripotency (E) and differentiation (F) factor levels in Scr-Ctrl and KD clones during RA-induced
differentiation. Expression levels were normalized to GAPDH (n = 3 independent biological experiments; error bars represent ±SEM).
(G) EBs derived from Scr-ctrl cells (left) and SET-KD clones (right). Note formation of cystic EBs in the SET-KD clones. Scale bar, 500 mm.
(H) Normal EB formation in SETa- and SETb-overexpressing clones. Scale bar, 500 mm.
(I) IF for NESTIN (red) in NPCs derived from Scr-ctrl (top) and SET-KD clones (bottom) without addback vectors. Phase-contrast images are
shown on the left. Scale bar, 200 mm.
(J) Quantification of (I) (n = 3 independent experiments; error bars represent ±SD; *p < 0.02, 2-tailed Student’s t test).
(K) Western blots using anti-HA antibodies showing HA-SETa and HA-SETb overexpression in addback clones. Arrowheads indicate SET
isoform positions.
(L) NESTIN immunostaining (red) in NPCs derived from Scr-ctrl cells (Scr-pN1, left), SET-KD cells (second from left), and in SET-KD-addback
SETa (second from right) or SETb (right) clones. Empty vectors (pN1) were used as controls. Nuclei were counterstained with DAPI (blue).
Phase contrast is shown at the bottom. Dotted white lines represent the border between EBs and differentiating NPCs. Scale bars, 100 mm.
(M) Quantification of the addback experiments (n = 3 independent experiments; error bars represent ±SD; *p < 0.05, 2-tailed t test).
(N) The relative abundance (in percentage) of the different cell types observed during NPC differentiation of Scr-ctrl, SET-KD and the
various addback clones.
(O) IF for TUJ1 (red) in differentiated neurons derived from Scr-ctrl (top) and SET-KD ESCs (middle and bottom). Nuclei were counter-
stained with DAPI (blue). Scale bar, 100 mm.
(P) Quantification of neuronal differentiation capacity in Scr-ctrl and KD clones (n = 3 independent experiments; error bars represent ±SD;
*p < 0.05, 2-tailed Student’s t test).
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(Figure 4D, top). To rule out the possibility that the forma-
tion of the circular colonies was due to the more slowly
differentiating SET-KD ESCs, we maintained these cultures
in RA-containing differentiation medium for 8 days. The
cells did not show any progression in differentiation and
slowly died (data not shown). These data indicate that
the SET-KD clones are defective in ectodermal differentia-
tion. To rule out the possibility that the expression changes
we observed were due to different readout of cells at
different stages of differentiation, we performed a time-
course differentiation experiment. The SET-KD cells were
differentiated for 6 days and the expression of pluripotency
and neuronal differentiation markers was quantified by
qPCR. Here also we observed a similar general trend in
marker expression in the KD clones, i.e., increased pluripo-
tency factor expression (Figure 4E) and increased endo-
dermal gene expression (Figure 4F, bottom). These results
suggest that the effects of SET on differentiation are not
due to different readouts of cells at different stages.
We next used non-directed differentiation into embryoid
bodies (EBs). By day 5, the SET-KD EBs gave rise to small
fluid-filled EBs, gradually growing into large EBs by day 8
(Figure 4G). Interestingly, many of the fluid filled EBs
formed from the SET-KD clones gave rise to spontaneously
beating cellular aggregates in suspension (Movie S2),
suggesting cardiomyocyte differentiation. Control EBs
appeared normal and did not produce any beating EBs.
Overexpression of either SETa or SETb did not alter EB for-
mation and differentiation (Figure 4H), suggesting that SET
is important, but not limiting, during this process.
Since RA differentiation of SET-KD cells yielded consider-
ably fewer NESTIN-positive cells, we further tested the po-
tential of the SET-KD cells to generate neuronal progenitor
cells (NPCs) (Lee et al., 2000). The SET-KD cells gave rise to a
significantly lower number of NPCs (by >50%, p < 0.05)
compared with controls (Figures 4I and 4J). To rule out un-
specific clonal or knockdown artifacts, we stably reintro-
duced SETa or SETb or a control pN1 vector into the SET-KD
clones (Figure 4K) and repeated the neuronal differentia-
tion. All clones formed normal EBs, but when differenti-
ated into NPCs, SETa addback only partially rescued the
differentiation phenotype (45%) (Figures 4L and 4M),
while SETb addback gave rise to fibroblast-like cells which,
curiously, stained positive for NESTIN (40%). We also
observed, once again, increased tendency to spontaneously
form beating foci only in the SET-KD clones (Figure 4N). As
expected, pN1 addback was similar to that of SET-KD
clones, failing to generate NPCs (10%), while the Scr-
ctrl differentiated normally. These data indicate that SET
plays an important function in neurogenesis.
We also tested whether the few emerging SET-KD NPCs
could give rise to mature neurons (Efroni et al., 2008; Lee
et al., 2000). The Scr-ctrl NPCs differentiated into Tuj1-pos-
itive neurons efficiently and formed networks (Figure 4O,
top). In contrast, SET-KD NPCs formed very few Tuj1-posi-
tive neurons and grew into fibroblast-like cells (Figures 4O
and 4P). Unexpectedly, the SET-KD clones gave rise to a
large number of single beating cells of varying shapes and
sizes (Movie S3). These findings once again indicate that
SET depletion propels ESCs toward an endodermal lineage
in the expense of neuroectoderm.
To gainmolecular insight, we performed gene expression
microarray analyses of RA-induced (4 days) SET-KD clones
versus Scr-ctrl. RA-induced SET-KD cells had 178 upregu-
lated and 419 downregulated genes compared with con-
trols (Figures 3D and S4A; Tables S2 and S3). Interestingly,
some of the upregulated genes are involved in the mainte-
nance of pluripotency (Figure S4A). Changes in selected
genes were reconfirmed by qRT-PCR (Figure S4B). Addi-
tional prominent examples of altered genes include several
Hox cluster genes (Hoxb13, Hoxd1, Hoxd4, Hoxd8, and
Hoxd13), which failed to be induced during differentiation.
Hoxd4, Hoxd8, and Hoxd13 were all shown to play impor-
tant roles during neuronal differentiation (Zha et al.,
2012), possibly explaining the aberrant neuronal induc-
tion phenotypes described above. In addition, SET-KD cells
failed to upregulate many genes involved in neurogenesis
(Table S4) confirmed by gene ontology analysis (Fig-
ure S4C). This suggests that SET acts as an upstream acti-
vator of a battery of transcription factors that are required
for neuronal differentiation. We cannot exclude the possi-
bility that SET is acting on a few neuronalmaster regulators
but in either case, SET, and particularly SETb, appears to
control neuronal gene expression during differentiation.
We next set out to test the effects of SETa on directed dif-
ferentiation to NPCs. For this we used the KH2 system,
which allowed us to knock in, using the FLPe recombinase,
SETa or SETb under a Dox-controlled promoter (Beard
et al., 2006). First, we assessed the effect of SET isoform
overexpression on pluripotency marker levels in self-re-
newing ESCs. qPCR analysis revealed no apparent effect
on pluripotency marker expression on SET-OE isoforms
for 2 days (Figure S4D). We next sought to understand
the effect of SET overexpression on ESC differentiation.
Individual SET isoforms were overexpressed in ESCs differ-
entiated into EBs for 4 days. We found that while SETb
overexpression had no discernible effect, SETa isoform
overexpression suppressed mesodermal (Brachyury) and
endodermal (Gata4) marker expression (Figure 5A), consis-
tent with the SET-depletion experiments, where endo-
dermal lineage markers were upregulated in the SET-
depleted cells (Figure S3F). To test the effects of SETa OE
on neuronal differentiation, we used both KH2 cells and
KH2-HA-SETa cells, differentiated in either the continued
presence of 0.5 mg/mL Dox, constantly driving SETa over-
expression, or with transient Dox (1 mg/mL) induction for
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Figure 5. SETa Is Essential for Maintaining the ESC State
(A) qRT-PCR analysis of the lineage-specific factors Nestin (blue), Brachyury (red), and Gata4 (green) in SET-control, SETa-OE, and
SETb-OE ESCs and in 4-day differentiated EBs (n = 3 independent experiments; error bars represent ±SD; *p < 0.05; 2-tailed t test).
Expression levels were normalized to GAPDH.
(B) Experimental layout of NPC differentiation from SET-OE ESCs.
(legend continued on next page)
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2 days only (Figure 5B). Continued SETa expres-
sion resulted in fewer and aberrant NPCs (75% less),
while transient SETa expression resulted in normal
NESTIN-positive NPCs, similarly to control KH2-ESCs
(Figures 5C–5E). Moreover, continuous SETb overexpres-
sion had no discernible effect on NPC generation. These
data show that high levels of SETa are detrimental for early
neuronal differentiation, and that SETa levels must decline
to ensure proper neurogenesis. Based on all combined data,
we propose that SETb is a lineage-choice factor that pro-
motes neurogenesis during early differentiation and that
SETa antagonizes this process.
Since SEToverexpression had dramatic effects on in vitro
differentiation, we next wished to examine the effects of
SETa and SETb on differentiation in vivo. We injected
SET-KD, SET-OE, and control cells subcutaneously in
severe-combined-immunodeficient (SCID) mice. Control
ESCs, uninduced KH2-HA-SETa ESCs, uninduced KH2-
HA-SETb ESCs, as well as SET-KD cells all formed tera-
tomas, with cells of all three germ layers present, although
the SET-KD teratomas appeared smaller. Unexpectedly,
when SETa was induced by addition of Dox to the mice’s
drinking water, no teratomas were produced (Figure S5A)
and we could not detect any undifferentiated cell mass
at the site of injection. This suggests that high levels of
SETa expression are incompatible with differentiation
both in vitro and in vivo, although only in vitro SETa pro-
moted proliferation. To further test this phenomenon,
we injected wild-type, SETa-KO, SETb-KO, and SET-DKO
ESCs into SCID mice. Remarkably, while both the
SETa-KO and the SET-DKO formed teratomas, albeit the
latter’s were smaller than controls, the SETb-KO ESCs
failed to make teratomas. Since the DKO were able to
differentiate in vivo, we attribute the failure of the
SETb-KO ESCs to generate teratomas to the elevated levels
SETa in these cells (Figure S3B). This is in line with our
SETa-OE experiment whereby increased levels of SETa re-
sulted in loss of teratoma-forming capacity (Figure S5A).
Finally, to test whether SET is essential for embryonic
development, we co-injected SET guide RNA (gRNA)
with Cas9 RNA into fertilized zygotes and found develop-
mental arrest (in 25% of the progeny) at around embry-
onic day 6.5 (Figures S5B and S5C).
SET Maintains H1 Dynamics on Chromatin in ESCs
SET has been recently reported to act as a histone H1 chap-
erone in HeLa cells (Kato et al., 2011). Since in ESCs, chro-
matin protein dynamics, including H1, is elevated (Chris-
tophorou et al., 2014; Melcer et al., 2012; Meshorer et al.,
2006), it was tempting to speculate that SETa might
contribute to this hyperdynamic plasticity. To test this,
we performed fluorescence recovery after photobleaching
(FRAP) analysis in SET-KD and control cells expressing his-
tone H1e-Cherry as conducted previously (Melcer et al.,
2012), and found that H1 recovery was significantly
reduced in the SET-KD cells compared with controls (p <
0.001) (Figures 5F and 5G). This was mostly due to differ-
ences in the bleach depth, which represent the highly mo-
bile fraction of the protein (Nissim-Rafinia and Meshorer,
2011). Since SETa is the predominant form in undifferenti-
ated ESCs, it is likely responsible for this effect, although
SETb is also present at low levels. To unequivocally distin-
guish between the contribution of the two SET isoforms,
we repeated the FRAP experiments in KH2 ESCs expressing
SETa or SETb separately, and found significantly elevated
H1 dynamics (p < 0.02) when SETa was overexpressed in
KH2 cells (Figures 5H and 5I). SETb showed a similar but
statistically insignificant trend. These data demonstrate
that SETa is chiefly responsible for histone H1 dynamics
in ESCs, but also that both variants possess H1 chaperone
activity to some extent. To confirm this, we also tested
the effect of SET depletion on histone H1e mobility in
differentiated cells (MEFs), and found comparable effects
(Figure S5D). SETa itself is also highly dynamic in both
ESCs and differentiated cells (Figure S5E), suggesting
weak and transient binding to chromatin. Repeated SET
ChIP and SETChIP-sequencing attempts were unsuccessful
with only a small fraction of successfully precipitated DNA,
supporting the dynamic nature of SET in ESCs. Taken
together, these results suggest that SET is a regulator of
linker histone dynamics in both ESCs and differentiated
cells, and imply that SETa is more efficient in maintaining
(C) Phase-contrast images of continued (top) or transient (bottom) SETa expression during NPC differentiation. Scale bar, 200 mm.
(D) Immunostaining for NESTIN in NPCs derived from KH2 cells (left), KH2 cells continually expressing SETa (middle), and KH2 cells
transiently expressing SETa (right). Nuclei were counterstained with DAPI (blue). Scale bar, 100 mm.
(E) Quantification of the transient and continuous addback experiments (n = 3 independent experiments; error bars represent ±SD;
*p < 0.05, 2-tailed Student’s t test).
(F) FRAP curves of histone H1e-Cherry in control (blue) and SET-KD (red, orange) cells (n = 3 independent experiments; ***p < 104;
2-tailed t test).
(G) Kinetic parameters of SET-KD FRAP experiments
(H) FRAP curves of H1e-Cherry in control (blue), SETa-OE (red), and SETb-OE (green) cells (n = 3 independent experiments; **p < 0.02,
2-tailed Student’s t test).
(I) Kinetic parameters of SET-OE FRAP experiments.
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a dynamic linker histone state, potentially contributing to
the hyperdynamics phenotype observed in ESCs (Melcer
et al., 2012; Meshorer et al., 2006).
DISCUSSION
In this study, using our clone library (Harikumar et al.,
2017) we identified SET, a nuclear protein previously not
implicated in ESC biology or pluripotency, to play a
role in maintaining ESCs as well as in lineage choice deci-
sions during differentiation. Notably, according to the hu-
man embryo resource (HumER: https://intranet.cmrb.eu/
Human_embryos/) (Vassena et al., 2011), SET is one of
the predominantly expressed proteins in early human
development. Based on computational analysis and condi-
tional OCT4 depletion, we show here that SET isoform
expression is regulated by two alternative promoters and
that in ESCs, SETa is controlled by multiple TFs, including
OCT4. The two SET isoforms differ only in their N-terminal
portion, while most of the protein (90%) is shared. We
propose that SETa is expressed in ESCs to allow SET’s bene-
ficial effects on proliferation and linker chaperone activ-
ities, without interfering with differentiation, while SETb
is essential for proper differentiation. Supporting this, we
found that co-injections of SET gRNA with Cas9 RNA into
fertilized zygotes results in halted development around em-
bryonic day 6.5. Therefore, since SETb0s specific roles, such
as activation of Hox cluster genes, apoptosis, etc., are not
compatible with the undifferentiated ESC state, whereas
SETa has a superior linker chaperone activity, and both
share similar properties in maintaining proliferation, the
switch between SETa and SETb is crucial for proper differ-
entiation. Immunoprecipitation followed by mass spec-
trometry analysis of SETa and SETb separately revealed
that althoughmost associated proteins are shared, each iso-
form has a handful of specific partners that likely act in
concert to confer specificity (Data not shown).
Histone chaperones such as SET affect various processes
of histone metabolism ranging from synthesis to deposi-
tion on chromatin (Avvakumov et al., 2011), and SET itself
has been shown to decondense sperm chromatin (Matsu-
moto et al., 1999). It is therefore tempting to speculate
that high levels of SET would act in a similar fashion in
ESCs, contributing to a decondensed chromatin conforma-
tion. Supporting this hypothesis, our FRAP analysis indi-
cates that SET is involved in histone H1 release from chro-
matin in ESCs. Hyperdynamic association of chromatin
proteins is a hallmark of pluripotency (Meshorer et al.,
2006), and was found to be controlled by histone acetyla-
tion and methylation (Melcer et al., 2012). In this regard,
SET seems to have opposing actions on chromatin plas-
ticity. On the one hand it increases linker histone dy-
namics, likely reflecting its role as an H1 chaperone (Kato
et al., 2011), on the other hand, SET restricts histone H4
acetylation, likely reflecting its association with the INHAT
complex (Seo et al., 2001). Increased histone acetylation
was shown to enhance chromatin protein dynamics in
ESCs (Melcer et al., 2012). How can these seemingly
opposing actions of SET be resolved? One option is that
its effect on chromatin protein dynamics is restricted to
linker histones and that core histones would not be simi-
larly affected. An additional option is that its function as
a linker histone chaperone ismore important than its func-
tion in restricting histone acetylation. The latter is some-
what more likely since increased histone acetylation in
ESCs, although it supports the pluripotent state, has very
little effect on gene expression (Boudadi et al., 2013; Hez-
roni et al., 2011). Taken together, our results suggest that
in addition to the other mechanisms previously described
that support a dynamic chromatin state in ESCs (Melcer
et al., 2012), high levels of SETa also act in a similar direc-
tion to keep chromatin in its characteristic hyperdynamic
ESC state.
In summary, the identification of SET, with its alternative
isoforms, as a regulator of proliferation and differentiation
in ESCs adds to the list of key factors that aid in maintain-
ing the stem cell state. SET is not a typical TF or chromatin
remodeler that directly regulates specific events in stem
cells. We envisage that SET acts as a potentiating and
balancing factor of several key processes in ESCs, rather
than a bona fide TF.Wewere able to identify different func-
tions of the two SET isoforms in ESCs and during differen-
tiation. Based on its intriguing expression pattern during
ESC differentiation, its role in embryonic development
should now be explored.
EXPERIMENTAL PROCEDURES
Detailed descriptions are provided in Supplemental Experimental
Procedures.
All mice were obtained from the Jackson Laboratory and main-
tained in the Whitehead Institute animal facility. All experiments
were approved by the Committee on Animal Care (CAC) at the
Massachusetts Institute of Technology, and animal procedures
were performed following the NIH guidelines.
All short hairpin RNAs (shRNAs)were selected from the TRC (The
RNAi Consortium, Broad Institute) database. The synthesized
shRNA oligos were cloned into the lentiviral vector pLVTHM. For
proliferation measurements, ESCs were plated in gelatin-coated
(0.2%) 6-well plates at a density of 105 per well. Dox was added
at a final concentration of 1 mg/mL andmediumwas replaced daily.
For neuronal differentiation, 23 106 ESCswere seeded on bacterial
culture dishes for EB formation. EBs were grown for 4 days in ESC
mediumwith 10% fetal bovine serumwithout leukemia inhibitory
factor (LIF). At day 4, EBs were plated on poly-L-ornithine/fibro-
nectin (PLO/FN)-coated plates for NPC differentiation in DMEM
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Nutrient Mixture-F12 (HAM) medium containing ITS (insulin/
transferrin/selenium) and FN. NPCs were grown for 3 days in
DMEM-F12 ITS/FNmedium and fixed with 4% paraformaldehyde.
For dopaminergic neuronal differentiation, NPCs were trypsi-
nized and plated on PLO/FN-coated plates. Cells were fed with
DMEM-F12 medium containing N2 plus medium/basic fibroblast
growth factor/ascorbic acid every day for 4 days. Differentiation
of dopaminergic neurons was induced by removing growth fac-
tors. Neuronal differentiation was continued for 10 days with
continued medium changes every 2 days.
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